| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell-Free Nucleic Acids | 9 | 2026 | 116 | 4.790 |
Why?
|
| Computational Biology | 13 | 2018 | 613 | 3.040 |
Why?
|
| DNA Methylation | 12 | 2026 | 730 | 2.580 |
Why?
|
| Gene Expression Profiling | 22 | 2019 | 1565 | 2.480 |
Why?
|
| Algorithms | 20 | 2018 | 2002 | 2.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 12 | 2011 | 700 | 2.050 |
Why?
|
| Databases, Genetic | 9 | 2015 | 288 | 1.500 |
Why?
|
| Genomics | 8 | 2015 | 898 | 1.490 |
Why?
|
| Software | 12 | 2023 | 693 | 1.490 |
Why?
|
| Gene Regulatory Networks | 8 | 2015 | 337 | 1.410 |
Why?
|
| Neoplasms | 10 | 2026 | 3334 | 1.390 |
Why?
|
| Chromatin | 9 | 2025 | 454 | 1.330 |
Why?
|
| Genome, Human | 8 | 2025 | 832 | 1.140 |
Why?
|
| Protein Isoforms | 3 | 2016 | 303 | 0.900 |
Why?
|
| Biomarkers, Tumor | 11 | 2026 | 1764 | 0.870 |
Why?
|
| Genome | 6 | 2023 | 417 | 0.860 |
Why?
|
| MicroRNAs | 5 | 2014 | 604 | 0.850 |
Why?
|
| Liver Neoplasms | 6 | 2026 | 831 | 0.840 |
Why?
|
| Sequence Analysis, RNA | 4 | 2015 | 271 | 0.810 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2026 | 450 | 0.810 |
Why?
|
| Alternative Splicing | 3 | 2016 | 224 | 0.790 |
Why?
|
| Disease | 2 | 2014 | 92 | 0.660 |
Why?
|
| Circulating Tumor DNA | 1 | 2021 | 82 | 0.620 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 244 | 0.620 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 548 | 0.610 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 2558 | 0.600 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 1133 | 0.600 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 319 | 0.590 |
Why?
|
| Epigenomics | 3 | 2017 | 111 | 0.580 |
Why?
|
| Chromosomes | 5 | 2023 | 91 | 0.580 |
Why?
|
| Humans | 56 | 2026 | 98076 | 0.580 |
Why?
|
| Phenotype | 6 | 2015 | 2638 | 0.530 |
Why?
|
| Chromosome Mapping | 4 | 2017 | 1061 | 0.530 |
Why?
|
| Ovarian Neoplasms | 5 | 2025 | 825 | 0.530 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 588 | 0.510 |
Why?
|
| Databases, Protein | 4 | 2012 | 52 | 0.490 |
Why?
|
| Genome-Wide Association Study | 5 | 2013 | 1850 | 0.490 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 2023 | 0.480 |
Why?
|
| Gene Expression | 5 | 2015 | 1320 | 0.470 |
Why?
|
| Bayes Theorem | 3 | 2013 | 422 | 0.470 |
Why?
|
| Models, Genetic | 5 | 2015 | 1005 | 0.460 |
Why?
|
| Linear Models | 2 | 2014 | 424 | 0.460 |
Why?
|
| Chromosomes, Human | 2 | 2016 | 69 | 0.450 |
Why?
|
| Cell Physiological Phenomena | 1 | 2015 | 24 | 0.450 |
Why?
|
| Computer Simulation | 6 | 2021 | 1147 | 0.440 |
Why?
|
| Sepsis | 1 | 2020 | 427 | 0.440 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 839 | 0.420 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 568 | 0.420 |
Why?
|
| Early Detection of Cancer | 3 | 2026 | 550 | 0.410 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 81 | 0.400 |
Why?
|
| Extracellular Vesicles | 2 | 2025 | 57 | 0.380 |
Why?
|
| Pattern Recognition, Automated | 3 | 2010 | 218 | 0.380 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 79 | 0.380 |
Why?
|
| Cost-Benefit Analysis | 2 | 2026 | 523 | 0.340 |
Why?
|
| Signal Transduction | 3 | 2008 | 3620 | 0.340 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1009 | 0.340 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2011 | 48 | 0.340 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2025 | 327 | 0.340 |
Why?
|
| Proteome | 2 | 2016 | 163 | 0.340 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 201 | 0.340 |
Why?
|
| RNA Splicing | 1 | 2012 | 163 | 0.320 |
Why?
|
| DNA | 2 | 2015 | 1274 | 0.320 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 197 | 0.320 |
Why?
|
| Multifactorial Inheritance | 1 | 2013 | 235 | 0.310 |
Why?
|
| Information Storage and Retrieval | 2 | 2010 | 130 | 0.310 |
Why?
|
| Cluster Analysis | 4 | 2012 | 401 | 0.280 |
Why?
|
| Cell Nucleus | 4 | 2025 | 615 | 0.280 |
Why?
|
| Datasets as Topic | 2 | 2021 | 84 | 0.270 |
Why?
|
| Fungal Proteins | 2 | 2005 | 148 | 0.260 |
Why?
|
| CpG Islands | 2 | 2018 | 177 | 0.250 |
Why?
|
| DNA, Neoplasm | 2 | 2018 | 267 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 1394 | 0.250 |
Why?
|
| Database Management Systems | 1 | 2006 | 44 | 0.240 |
Why?
|
| alpha-Fetoproteins | 1 | 2026 | 48 | 0.240 |
Why?
|
| Transcription Factors | 4 | 2017 | 1717 | 0.230 |
Why?
|
| Biomarkers | 3 | 2023 | 2020 | 0.230 |
Why?
|
| Models, Statistical | 3 | 2017 | 601 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 911 | 0.220 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2063 | 0.220 |
Why?
|
| Data Interpretation, Statistical | 4 | 2014 | 313 | 0.220 |
Why?
|
| Data Mining | 2 | 2017 | 45 | 0.210 |
Why?
|
| Female | 13 | 2026 | 51535 | 0.210 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2005 | 72 | 0.210 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 646 | 0.210 |
Why?
|
| Animals | 17 | 2025 | 28894 | 0.210 |
Why?
|
| Natural Killer T-Cells | 1 | 2024 | 50 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2025 | 288 | 0.200 |
Why?
|
| Models, Biological | 3 | 2018 | 1807 | 0.190 |
Why?
|
| Cell Culture Techniques | 1 | 2024 | 196 | 0.190 |
Why?
|
| DNA Damage | 1 | 2025 | 399 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 3 | 2023 | 977 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 1 | 2025 | 356 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 630 | 0.190 |
Why?
|
| Internet | 3 | 2014 | 358 | 0.190 |
Why?
|
| Likelihood Functions | 3 | 2016 | 258 | 0.180 |
Why?
|
| Computer Graphics | 3 | 2007 | 99 | 0.180 |
Why?
|
| Machine Learning | 1 | 2026 | 408 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2024 | 330 | 0.170 |
Why?
|
| Mutation | 3 | 2023 | 4392 | 0.170 |
Why?
|
| Methylation | 2 | 2020 | 294 | 0.170 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2783 | 0.170 |
Why?
|
| Exome | 1 | 2022 | 145 | 0.170 |
Why?
|
| Aging | 1 | 2006 | 770 | 0.170 |
Why?
|
| Sensitivity and Specificity | 2 | 2026 | 1945 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2025 | 665 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2019 | 1094 | 0.160 |
Why?
|
| Neoplasm, Residual | 1 | 2022 | 206 | 0.160 |
Why?
|
| Liquid Biopsy | 1 | 2020 | 50 | 0.160 |
Why?
|
| Heterochromatin | 2 | 2017 | 27 | 0.160 |
Why?
|
| Regression Analysis | 2 | 2012 | 578 | 0.150 |
Why?
|
| Markov Chains | 2 | 2013 | 146 | 0.150 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 199 | 0.150 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 236 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2012 | 447 | 0.140 |
Why?
|
| Centromere | 2 | 2016 | 28 | 0.140 |
Why?
|
| Cell Line | 4 | 2016 | 2483 | 0.140 |
Why?
|
| Cytological Techniques | 1 | 2018 | 30 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 668 | 0.140 |
Why?
|
| Molecular Conformation | 1 | 2018 | 112 | 0.130 |
Why?
|
| Chromosomes, Insect | 1 | 2017 | 9 | 0.130 |
Why?
|
| Biopsy | 1 | 2021 | 1224 | 0.130 |
Why?
|
| User-Computer Interface | 2 | 2010 | 194 | 0.130 |
Why?
|
| Prognosis | 2 | 2025 | 4116 | 0.130 |
Why?
|
| Genome, Insect | 1 | 2017 | 81 | 0.120 |
Why?
|
| Workflow | 1 | 2017 | 85 | 0.120 |
Why?
|
| Genotype | 2 | 2013 | 1888 | 0.120 |
Why?
|
| Mice | 6 | 2025 | 12698 | 0.120 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 17 | 0.120 |
Why?
|
| ROC Curve | 1 | 2018 | 794 | 0.120 |
Why?
|
| Protein Interaction Maps | 2 | 2016 | 55 | 0.120 |
Why?
|
| Genes, Essential | 1 | 2015 | 19 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2024 | 1646 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 745 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2020 | 520 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2018 | 357 | 0.110 |
Why?
|
| Nucleosomes | 2 | 2012 | 63 | 0.110 |
Why?
|
| Chromosomes, Fungal | 1 | 2015 | 16 | 0.110 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 40 | 0.110 |
Why?
|
| Bacteria | 1 | 2020 | 545 | 0.110 |
Why?
|
| Metagenomics | 1 | 2016 | 106 | 0.110 |
Why?
|
| Saccharomycetales | 1 | 2015 | 15 | 0.110 |
Why?
|
| Genomic Library | 1 | 2014 | 30 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 1099 | 0.110 |
Why?
|
| Genome, Fungal | 1 | 2015 | 42 | 0.110 |
Why?
|
| Papio | 1 | 2015 | 91 | 0.110 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 652 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1535 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2022 | 1527 | 0.110 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 33 | 0.110 |
Why?
|
| Schizosaccharomyces | 1 | 2015 | 57 | 0.110 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 473 | 0.110 |
Why?
|
| Forecasting | 1 | 2015 | 295 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 104 | 0.100 |
Why?
|
| RNA Isoforms | 1 | 2013 | 5 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2014 | 67 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 2373 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 183 | 0.100 |
Why?
|
| Species Specificity | 2 | 2006 | 690 | 0.100 |
Why?
|
| Pan troglodytes | 1 | 2015 | 203 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3272 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 147 | 0.100 |
Why?
|
| Middle Aged | 5 | 2026 | 29427 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 194 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2025 | 9711 | 0.090 |
Why?
|
| Population Groups | 1 | 2012 | 44 | 0.090 |
Why?
|
| Oncogenes | 1 | 2012 | 102 | 0.090 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 45 | 0.090 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 99 | 0.090 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 538 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 2896 | 0.090 |
Why?
|
| Proteomics | 2 | 2025 | 279 | 0.090 |
Why?
|
| Aged | 5 | 2026 | 21758 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 171 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 102 | 0.080 |
Why?
|
| Male | 6 | 2026 | 47075 | 0.080 |
Why?
|
| RNA | 1 | 2015 | 595 | 0.080 |
Why?
|
| Exons | 1 | 2012 | 451 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1032 | 0.080 |
Why?
|
| Postmortem Changes | 1 | 2010 | 9 | 0.080 |
Why?
|
| Histones | 1 | 2012 | 370 | 0.080 |
Why?
|
| Access to Information | 1 | 2010 | 30 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 298 | 0.070 |
Why?
|
| Unified Medical Language System | 1 | 2009 | 1 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 2457 | 0.070 |
Why?
|
| Systems Biology | 1 | 2009 | 51 | 0.070 |
Why?
|
| Biometry | 1 | 2009 | 70 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 2555 | 0.070 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 18 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1752 | 0.060 |
Why?
|
| Diploidy | 2 | 2018 | 36 | 0.060 |
Why?
|
| Precision Medicine | 2 | 2022 | 503 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2026 | 4823 | 0.060 |
Why?
|
| Systems Integration | 1 | 2006 | 36 | 0.060 |
Why?
|
| Models, Molecular | 3 | 2016 | 1391 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 479 | 0.060 |
Why?
|
| Transcriptome | 1 | 2012 | 820 | 0.060 |
Why?
|
| Sample Size | 1 | 2006 | 130 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 310 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2025 | 2585 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 804 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2017 | 370 | 0.060 |
Why?
|
| Demography | 1 | 2026 | 193 | 0.060 |
Why?
|
| Bias | 1 | 2026 | 139 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 2005 | 64 | 0.060 |
Why?
|
| Tumor Escape | 1 | 2025 | 55 | 0.060 |
Why?
|
| Adult | 2 | 2025 | 29538 | 0.050 |
Why?
|
| Platinum | 1 | 2025 | 68 | 0.050 |
Why?
|
| Binding Sites | 1 | 2007 | 1159 | 0.050 |
Why?
|
| Statistics as Topic | 1 | 2005 | 230 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 2888 | 0.050 |
Why?
|
| Base Sequence | 1 | 2007 | 2222 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2024 | 78 | 0.050 |
Why?
|
| Asthma | 1 | 2012 | 1078 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1554 | 0.050 |
Why?
|
| Glypicans | 1 | 2023 | 7 | 0.050 |
Why?
|
| Cisplatin | 1 | 2025 | 578 | 0.050 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 85 | 0.050 |
Why?
|
| Polycomb-Group Proteins | 2 | 2012 | 10 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2025 | 977 | 0.040 |
Why?
|
| Logistic Models | 1 | 2025 | 1275 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 446 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1284 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2021 | 72 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 617 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1995 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 4071 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2023 | 527 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 2036 | 0.040 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 663 | 0.040 |
Why?
|
| Brain | 1 | 2010 | 2430 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 7389 | 0.040 |
Why?
|
| Exosomes | 1 | 2019 | 66 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 148 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 71 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 69 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 204 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2017 | 204 | 0.030 |
Why?
|
| Chromosome Positioning | 1 | 2016 | 4 | 0.030 |
Why?
|
| Tomography, X-Ray | 1 | 2016 | 15 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2023 | 1285 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2016 | 77 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 86 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 118 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 38 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 581 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Risk Factors | 1 | 2025 | 6232 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 164 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 132 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 130 | 0.030 |
Why?
|
| Disease Progression | 1 | 2018 | 1610 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2016 | 461 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 263 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 219 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2015 | 194 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 731 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 53 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 750 | 0.020 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2012 | 32 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 156 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2012 | 77 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 139 | 0.020 |
Why?
|
| Azacitidine | 1 | 2013 | 152 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 195 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 109 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 178 | 0.020 |
Why?
|
| Lysine | 1 | 2012 | 181 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 480 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2015 | 571 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 10972 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 902 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 502 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2005 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 767 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2016 | 1072 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3598 | 0.020 |
Why?
|